ArticleCardiovascular diabetology2017

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes.

Javad Habibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.